TNF-α (g.-308 G > A) and ADIPOQ (g. + 45 T > G) gene polymorphisms in type 2 diabetes and microvascular complications in the region of Punjab (North-West India)

Current Eye Research

Volumn 39, Issue 10, 2014, Pages 1042-1051

  Sikka, Ruhi ^a   Raina, Priyanka ^a   Matharoo, Kawaljit ^a   Bandesh, Khushdeep ^a,b   Bhatia, Rajan ^c   Chakrabarti, Subhabrata ^d   Bhanwer, A J S ^a  

^a GURU NANAK DEV UNIVERSITY   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^c Om Prakash Eye Hospital   (India)

^d L V PRASAD EYE INSTITUTE   (India)

Author keywords

Diabetic nephropathy; diabetic retinopathy; North West Indian population; SNP; type 2 diabetes

Indexed keywords

ADIPONECTIN; CHOLESTEROL; CREATININE; LIPOPROTEIN; MESSENGER RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UREA; ADIPOQ PROTEIN, HUMAN;

ADULT; ALLELE; ANTHROPOMETRIC PARAMETERS; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN SECONDARY STRUCTURE; PUNJABI (PEOPLE); RISK ASSESSMENT; RISK FACTOR; FEMALE; GENETICS; GENOTYPING TECHNIQUE; INDIA; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADIPONECTIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPING TECHNIQUES; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907082052     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2014.892998     Document Type: Article

References (59)

1. Simon D. Epidemiological features of type 2 diabetes. Rev Prat 2010;60:469-473.
2. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010;375:408-418.
3. Unwin N, Gan D, Whiting D. The IDF Diabetes Atlas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 2010;87:2-3.
4. Mohan V, Shah S, Saboo B. Current glycemic status and diabetes related complications among Type 2 Diabetes patients in India: data from the A1chieve study. J Assoc Physicians India 2013;61:12-15.
5. Unnikrishnan R, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V. Prevalence and Risk factors of nephropathy in an urban population: the Chennai urban rural epidemiology study. Diabetes Care 2007;30:2019-2024.
6. Mahler RJ, Adler AL. Type 2 diabetes mellitus: update on diagnosis, pathophysiology, and treatment. J Clin Endocr Metab 1999;84:1165-1171.
7. Samaras K, Botelho NK, Chisholm DJ. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity 2010;18:884-889.
8. Fantuzzi G. Adiponectin and inflammation: consensus and controversy. Am Acad Aller, Asthma Immunol. J Allergy Clin Immunol 2008;121:326-330.
9. Lara-Castro C, Fu Y, Chung BH, Garvey WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007;18:263-270.
10. Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008;19:433-442.
11. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953.
12. Matsuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005;6:7-14.
13. Freedman BI, Bostrom M, Daeihagh P, Bowden DW. Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol 2007;2:1306-1316.
14. Nishimura M, Hashimoto T, Kobayashi H, Fukukda T, Okino K, Yamamoto N, et al. Possible involvement of TNFalpha in left ventricular remodeling in hemodialysis patients. J Nephrol 2003;16:641-649.
15. Satoh J, Yagihashi S, Toyota T. The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy. Exp Diabesity Res 2003;4:65-71.
16. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al. Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005;54: 1559-1565.
17. Yeo E, Hwang J, Park JE, Choi YJ, Huh KB, Kim WY, et al. Tumor necrosis factor (TNF-a) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes. Yonsei Med J 2010;51:519-525.
18. Boraska V, Rayner NW, Groves CJ, Frayling TM, Diakite M, Rockett KA, et al. Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet 2010;11:69.
19. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, Agardh C. Association between LTA, TNF and AGER polymorphisms and late diabetic complications. Plos One 2008;3:e2246.
20. Prasad P, Tiwari AK, Kumar KMP, Ammini AC, Gupta A, Gupta R, et al. Association of TGFb1, TNFa, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians. BMC Med Genet 2007; 8:20.
21. Yoshioka K, Yoshida T, Takakura Y, Umekawa T, Kogure A, Toda H, et al. Relationship between polymorphisms 804C/A and 252A/G of lymphotoxin-a gene and 308G/A of tumor necrosis factor a gene and diabetic retinopathy in Japanese patients with type 2 diabetes mellitus. Metabolism 2006;55:1406-1410.
22. Mohindru K, Changotra H, Sehajpal PK. Lack of association between TNF-308 polymorphism and end stage renal disease in North Indian population. Int J Hum Genet 2004;4:61-64.
23. Choe EY, Wang HJ, Kwon O, Kim KJ, Kim BS, Lee B, et al. Variants of adiponectin gene and diabetic microvascular complications in patients with type 2 diabetes. Metabolism Clin Exp. 2012;62:677-685.
24. Biswas D, Vettriselvi V, Choudhury J, Jothimalar R. Adiponectin gene polymorphism and its association with type 2 diabetes mellitus. Ind J Clin Biochem 2011;26: 172-177.
25. American Diabetes Association: standards of medical care in diabetes. Diabetes Care 2011;34:S11-S61.
26. Levey AS, De Jong PE, Coresh J, Nahas NE, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kid Int 2011;80:17-28.
27. Early Treatment Diabetic Retinopathy Study Research Group. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98:S766-S785.
28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for 439 extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
29. Gupta V, Sehajpal PK. Rapid detection of single nucleotide (-308) polymorphism in TNF-a promoter using ARMSPCR. Curr Sci India 2003;85:1521-1523.
30. Xita N, Georgiou I, Tsatsoulis A, Kourtis A, Kukuvitis A, Panidis D. A polymorphism in the resistin gene promoter is associated with Body Mass Index in women with polycystic ovary syndrome. Fertil Steril 2004;82:1466-1467.
31. Gauderman WJ. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 2002;155: 478-484.
32. Zuker M, Sankoff, D. RNA secondary structures and their prediction. Bull Math Biol 1984;46:591-621.
33. Snehalatha C, Viswanathan V, Ramachandran. A cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003;26:1380-1384.
34. Rincon-Choles H, Thameem F, Lehman DM, Arya R, Arar N, Duggirala R, et al. Genetic basis of diabetic nephropathy. Am J Therapeut 2005;12:555-561.
35. Li FY, Cheng KK, Lam KS, Vanhoutte PM, Xu A. Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol 2011;203:167-180.
36. Vincent AM, Callaghan BC, Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011;7:573-583.
37. Manchanda PK, Kumar A, Kaul A, Mittal RD. Correlation between a gene polymorphism of tumor necrosis factor-a (G/A) and end stage renal disease: a pilot study from north India. Clin Chim Acta 2006;370:152-157.
38. Qi L, Li T, Rimm E, Zhang C, Rifai N, Hunter D, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005;54:1607-1610.
39. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002;51:2306-2312.
40. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102:1296-1301.
41. Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BBbinding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002;105:2893-2898.
42. Arnold F, Parasuraman S, Arokiasamy P, Kothari M. Nutrition in India, National family health survey-3. 2009. Available from http://www.nfhsindia.org/nfhs3.pdf [last accessed 7 Dec 2013].
43. Matharoo K, Arora P, Bhanwer AJS. Association of adiponectine (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphism with type 2 diabetes in North Indian population of Punjab. Gene 2013;527:228- 234.
44. Sun H, Gong ZC, Yin JY, Liu HL, Liu YZ, Guo ZW, et al. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. Br J Clin Pharmacol 2008;65: 917-926.
45. Gonzalez-Sanchez JL, Zabena CA, Martinez-Larrad MT, Fernandez-Pérez C, Perez-Barba M, Laakso M, et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 2005;13:807-812.
46. Lee YY, Lee NS, Cho YM, Moon MK, Jung HS, Park YJ, et al. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med 2005;22:569-575.
47. Fumeron F, Aubert R, Siddiq A, Betoulle D, Péan F, Hadjadj S, et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004;53:1150-1157.
48. Gibson F, Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004;53:2977-2983.
49. Saxena M, Srivastava N, Banerjee M. Genetic association of adiponectin gene polymorphisms (+45 T/G and +10211 T/G) in type 2 diabetes in North Indians. Diabet Metabol Syndr: Clin Res Rev 2012;6:65-69.
50. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an Island: the flip-flop phenomenon. Am J Hum Gen 2007;80:531-538.
51. Zietz B, Buechler C, Kobuch K, Neumeier M, Scholmerich J, Schaffler A. Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2. Exp Clin Endocrinol Diabetes 2008;116:532-536.
52. Watkins WS, Thara R, Mowry BJ, Zhang Y, Witherspoon DJ, Tolpinrud W, et al. Genetic variation in South Indian castes: evidence from Y-chromosome, mitochondrial, and autosomal polymorphisms. Bio Med Central 2008;9: 2156-2986.
53. Bhasin MK,Walter H, Danker-Hopfe H. The distribution of genetical, morphological and behavioral traits among the peoples on Indian region. J Hum Ecol 1992;6:266-267.
54. Nemec P, Goldbergova MP, Stouracova M, Vasku A, Soucek M, Gatterova J. Polymorphism in the tumor necrosis factor gene promoter is associated with severity of rheumatoid arthritis in the Czech population. Clin Rheumatol 2008;27:59-65.
55. Cvetkovic JT, Jonsson SW, Stegmayr B, Rantapaa-Dahlqvist S, Lefvert AK. Susceptibility for and clinical manifestations of Rheumatoid Arthritis are associated with polymorphisms of the TNF-a, IL-1b, and IL-1Ra Genes. J Rheumatol 2002;29:212-219.
56. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular vessel walls. Horm Metab Res 2000;32:47-50.
57. Seo SW, Yang J, Jung GY. Quantitative correlation between mRNA secondary structure around the region downstream of the initiation codon and translational efficiency in Escherichia Coli. Biotechnol Bioeng 2009;104: 611-616.
58. Gupta H, Sakharwade SC, Angural A, Kotambail A, Bhat GK, Hande MH, et al. Evidence for genetic linkage between a polymorphism in the GNAS gene and malaria in South Indian population. Acta Trop 2013;128: 571-577.
59. Rivero A, Mora C, Muros M, García J, Herrera H, Navarro- González JF. Pathogenic perspectives for the role of inflammation in diabetic nephropathy. Clin Sci 2009;116: 479-492.